The Protein World GLP-1 Programme is a prescription-based weight management programme built around Tirzepatide, a GLP-1–based compound delivered via a once-weekly pen. Access is limited and subject to clinical review.

About the Programme

The Protein World GLP-1 Programme is designed for individuals seeking a structured, medically supervised approach to weight management.

The programme is based on Tirzepatide, a dual-acting GLP-1 and GIP receptor agonist that works with your body’s natural appetite-regulation pathways.

Tirzepatide is administered once weekly using a discreet, pre-filled pen as part of a clinician-reviewed programme.

Important Clarification

This programme does not supply branded Mounjaro.

Tirzepatide is the active ingredient used in Mounjaro; however, this programme provides Protein World–branded Tirzepatide pens, dispensed for private use where clinically appropriate.

How It Works

Tirzepatide works by activating GLP-1 and GIP receptors found naturally in the body. These receptors are involved in appetite regulation, satiety, and metabolic signalling.

By supporting these pathways, the programme helps many individuals feel fuller for longer and better manage calorie intake as part of a broader weight-management plan.

Results vary between individuals and depend on personal factors, consistency, and adherence to medical guidance.

What’s Included

• Protein World–branded Tirzepatide pen
  

• Once-weekly dosing programme
  

• Clinician review and suitability assessment
  

• Ongoing programme oversight
  

• Structured dose progression where appropriate
  

This programme is not a supplement and is not sold as a retail product.

Dosing & Administration

• Format: Pre-filled pen
  

• Frequency: Once weekly
  

• Dose progression: Determined by clinical review
  

• Use: Self-administered following guidance
  

Full instructions are provided as part of the programme once access is granted.

Access & Eligibility

Access to the Protein World GLP-1 Programme is private and limited.

All participants must:

• Complete an eligibility questionnaire
  

• Undergo clinical review
  

• Be deemed suitable before access is granted
  

Submitting information does not guarantee access.

Regulatory & Medical Information

GLP-1 programmes fall within a regulated medical category.

This programme is:

• Prescription-based
  

• Clinician-reviewed
  

• Dispensed under Protein World’s Hong Kong pharmaceutical licence
  

It is not available as a public retail product.

What This Page Is (and Isn’t)

This page is:

• Information about a private programme
  

• An overview of how the programme works
  

• A pathway to request access
  

This page is not:

• A direct purchase
  

• A guarantee of access
  

• A public product launch
  

Payment is only requested after approval and invitation, where applicable.

Safety Information

As with any prescription-based programme, Tirzepatide may not be suitable for everyone and may be associated with side effects.

A clinician will review your information to determine whether this programme is appropriate for you.

You should only participate if approved through the official review process.

*This product is non-returnable.*